234 related articles for article (PubMed ID: 24300434)
21. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
22. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
[TBL] [Abstract][Full Text] [Related]
23. Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.
Ganança L; Galfalvy HC; Oquendo MA; Hezghia A; Cooper TB; Mann JJ; Sublette ME
Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():38-44. PubMed ID: 28410668
[TBL] [Abstract][Full Text] [Related]
24. CSF monoamine metabolites of depressed patients during illness and after recovery.
Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
[TBL] [Abstract][Full Text] [Related]
25. Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy.
Chang JP; Lin CY; Lin PY; Shih YH; Chiu TH; Ho M; Yang HT; Huang SY; Gałecki P; Su KP
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):273-278. PubMed ID: 28536068
[TBL] [Abstract][Full Text] [Related]
26. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
27. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
[TBL] [Abstract][Full Text] [Related]
28. Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices.
Agren H; Terenius L
J Affect Disord; 1985 Jul; 9(1):25-34. PubMed ID: 2410472
[TBL] [Abstract][Full Text] [Related]
29. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
Narayan M; Srinath S; Anderson GM; Meundi DB
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
[TBL] [Abstract][Full Text] [Related]
31. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
Miura K; Hughes MCB; Ungerer JP; Green AC
Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
[TBL] [Abstract][Full Text] [Related]
32. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder.
McNamara RK; Welge JA
Bipolar Disord; 2016 May; 18(3):300-6. PubMed ID: 27087497
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
Parletta N; Niyonsenga T; Duff J
PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
[TBL] [Abstract][Full Text] [Related]
35. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
36. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania.
Sublette ME; Bosetti F; DeMar JC; Ma K; Bell JM; Fagin-Jones S; Russ MJ; Rapoport SI
Bipolar Disord; 2007 Nov; 9(7):759-65. PubMed ID: 17988367
[TBL] [Abstract][Full Text] [Related]
37. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters.
Jokinen J; Nordström AL; Nordström P
Arch Suicide Res; 2007; 11(2):187-92. PubMed ID: 17453696
[TBL] [Abstract][Full Text] [Related]
38. A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
Lin PY; Chiu CC; Huang SY; Su KP
J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939
[TBL] [Abstract][Full Text] [Related]
39. Salivary prolactin as a marker for central serotonin turnover.
Lindell SG; Suomi SJ; Shoaf S; Linnoila M; Higley JD
Biol Psychiatry; 1999 Aug; 46(4):568-72. PubMed ID: 10459408
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
